Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NAC for Mitigation of Chemotherapy-Related Cognitive Impairment in Ovarian Cancer
NCT04520139Phase 2Recruiting
- Sponsor
- University of California, Irvine
- Start
- May 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in chemotherapy-induced cognitive impairment (CICI), sponsored by University of California, Irvine. Started May 2026; status: recruiting.
02
Drugs
acetylcysteine
03
Conditions
chemotherapy-induced cognitive impairment (CICI)
Beyond the preview
Go deeper on NCT04520139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04520139.